Alumis Inc. (ALMS)
NASDAQ: ALMS · Real-Time Price · USD
10.35
+0.88 (9.29%)
At close: Sep 2, 2026, 4:00 PM EDT
10.57
+0.22 (2.12%)
Pre-market: Sep 3, 2026, 5:22 AM EDT
Alumis Employees
As of June 30, 2026, Alumis had 239 total employees, including 237 full-time and 2 part-time employees. The number of employees increased by 12 or 5.29% compared to the same quarter last year.
Employees
239
Change
12
Growth
5.29%
Revenue / Employee
$30,954
Profits / Employee
-$1,836,640
Market Cap
1.34B
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Jun 30, 2026 | 239 | 12 | 5.29% | 237 | 2 |
| Mar 31, 2026 | 227 | 43 | 23.37% | 225 | 2 |
| Dec 31, 2025 | 224 | 54 | 31.76% | 221 | 3 |
| Sep 30, 2025 | 223 | 76 | 51.70% | 221 | 2 |
| Jun 30, 2025 | 227 | 97 | 74.62% | 225 | 2 |
| Mar 31, 2025 | 184 | 75 | 68.81% | 182 | 2 |
| Dec 31, 2024 | 170 | 61 | 55.96% | 168 | 2 |
| Sep 30, 2024 | 147 | 38 | 34.86% | 145 | 2 |
| Jun 30, 2024 | 130 | - | - | 128 | 2 |
| Mar 31, 2024 | 109 | - | - | 107 | 2 |
| Dec 31, 2023 | 109 | - | - | 107 | 2 |
Related Stocks
| Company Name | Employees |
|---|---|
| Immatics | 704 |
| MannKind | 592 |
| MeiraGTx Holdings | 393 |
| Omeros | 175 |
| MoonLake Immunotherapeutics | 130 |
| Alpha Tau Medical | 121 |
| ORIC Pharmaceuticals | 111 |
| Vor Biopharma | 76 |
ALMS News
- 14 minutes ago - Alumis downgraded to Neutral from Buy at Guggenheim - TheFly
- 17 hours ago - Alumis rises 10.7% - TheFly
- 22 hours ago - Alumis price target lowered to $37 from $55 at Oppenheimer - TheFly
- 22 hours ago - Alumis price target lowered to $25 from $51 at Wells Fargo - TheFly
- 22 hours ago - Alumis price target lowered to $29 from $39 at Morgan Stanley - TheFly
- 23 hours ago - Alumis upgraded to Buy from Neutral at H.C. Wainwright - TheFly
- 1 day ago - Alumis price target lowered to $27 from $35 at Baird - TheFly
- 1 day ago - Alumis price target lowered to $25 from $51 at Wells Fargo - TheFly